Moderna news, latest stories & analysis

Find today's trending Moderna news & headlines

Moderna stock popped 15% on Thursday: explore why
  • Moderna reported mid-stage trial data for its experimental melanoma vaccine.
  • American Cancer Society estimates 100,000 diagnosis of melanoma this year in U.S.
  • Moderna stock is still down more than 50% versus its year-to-date high.
December 14, 2023

More breaking stories

Other topics

AED
ARS
BP
BRL
BT
COP
CZK
DKK
FTX
GMX
GSK
IDR
INR
KRW
Nio
OKX
PHP
PKR
PLN
RUB
THB
TRY
TWD
ZAR